Companies & Industry »Company News»Company News Details
Company News Details

BSE   23 Jun 17 | 12:00 AM

525.10 -0.95 (-0.18%)
Mkt Price (Rs)   Chg Rs (Chg %)
Code: 532321
Face Value: N.A.

NSE   23 Jun 17 | 12:00 AM

525.60 0.3 (0.06%)
Mkt Price (Rs)   Chg Rs (Chg %)
Code: CADILAHC
Performance
1 Week : Rs 531.15 (-1.14%)
1 Month : Rs 426.80 (23.03%)
1 Year : Rs 312.25 (68.17%)
change companytradenow
Back

Cadila's stock rising: Credit Suisse

Reuters / 18 Jul 12 | 11:50 AM

Credit Suisse initiates coverage on Cadila Healthcare with an "outperform" rating and a target price of Rs 970.

Investment bank says the midcap drug maker has demonstrated "strong execution" in the United States, with a portfolio mix focusing on low competition products such as nasal sprays and injectable drugs.

Widgets Magazine

USFDA approval of its facilities in Moraiya, part of Gujarat, will re-start new approvals of its drugs in the US market, Credit Suisse adds.

"Cadila is moving up the value-chain with the launch of difficult-to formulate products and its strong execution record provides multi-year growth visibility."

Widgets Magazine

Sensex

Company Price Gain (%)
Power Grid Corpn205.301.84
Sun Pharma.Inds.543.950.97
Wipro256.850.86
ICICI Bank291.500.71
Dr Reddy's Labs2,642.500.50

Online Portfolio

You can create Online Portfolio here using the below button.

Widgets Magazine